Franklin, Parlapiano, Turner & Welch, LLC Novartis Ag Transaction History

Franklin, Parlapiano, Turner & Welch, LLC

  • $371 Million
  • Q1 2025

A detailed history of Franklin, Parlapiano, Turner & Welch, LLC transactions in Novartis Ag stock. As of the latest transaction made, Franklin, Parlapiano, Turner & Welch, LLC holds 75,620 shares of NVS stock, worth $9.22 Million. This represents 2.27% of its overall portfolio holdings.

Number of Shares
75,620
Previous 75,450 0.23%
Holding current value
$9.22 Million
Previous $7.34 Million 14.82%
% of portfolio
2.27%
Previous 1.99%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 25, 2025
BUY
$97.14 - $115.57 $16,513 - $19,646
170 Added 0.23%
75,620 $8.43 Million
Q4 2024

Jan 23, 2025
BUY
$96.78 - $117.18 $19,936 - $24,139
206 Added 0.27%
75,450 $7.34 Million
Q3 2024

Oct 22, 2024
SELL
$106.13 - $120.89 $24,728 - $28,167
-233 Reduced 0.31%
75,244 $8.65 Million
Q2 2024

Jul 31, 2024
SELL
$92.57 - $107.37 $28,789 - $33,392
-311 Reduced 0.41%
75,477 $8.04 Million
Q1 2024

May 02, 2024
SELL
$95.27 - $108.47 $27,818 - $31,673
-292 Reduced 0.38%
75,788 $7.33 Million
Q4 2023

Jan 26, 2024
SELL
$92.27 - $101.54 $76,953 - $84,684
-834 Reduced 1.08%
76,080 $7.68 Million
Q3 2023

Oct 31, 2023
SELL
$94.73 - $105.13 $151,473 - $168,102
-1,599 Reduced 2.04%
76,914 $7.83 Million
Q2 2023

Jul 21, 2023
SELL
$92.52 - $104.91 $175,788 - $199,329
-1,900 Reduced 2.36%
78,513 $7.92 Million
Q1 2023

May 02, 2023
BUY
$80.03 - $92.81 $13,765 - $15,963
172 Added 0.21%
80,413 $7.4 Million
Q4 2022

Jan 31, 2023
BUY
$75.55 - $92.52 $35,735 - $43,761
473 Added 0.59%
80,241 $7.28 Million
Q3 2022

Nov 03, 2022
BUY
$74.61 - $87.26 $71,252 - $83,333
955 Added 1.21%
79,768 $6.06 Million
Q2 2022

Jul 20, 2022
BUY
$80.52 - $93.75 $75,366 - $87,750
936 Added 1.2%
78,813 $6.66 Million
Q1 2022

May 02, 2022
BUY
$80.11 - $90.62 $319,318 - $361,211
3,986 Added 5.39%
77,877 $6.83 Million
Q4 2021

Jan 21, 2022
BUY
$79.7 - $88.13 $422,489 - $467,177
5,301 Added 7.73%
73,891 $6.46 Million
Q3 2021

Oct 21, 2021
BUY
$81.78 - $95.14 $18,564 - $21,596
227 Added 0.33%
68,590 $5.61 Million
Q2 2021

Jul 30, 2021
BUY
$85.24 - $94.15 $228,272 - $252,133
2,678 Added 4.08%
68,363 $6.24 Million
Q1 2021

May 05, 2021
BUY
$83.5 - $98.47 $241,899 - $285,267
2,897 Added 4.61%
65,685 $5.62 Million
Q4 2020

Jan 22, 2021
BUY
$78.07 - $94.43 $112,655 - $136,262
1,443 Added 2.35%
62,788 $5.93 Million
Q3 2020

Oct 30, 2020
BUY
$82.14 - $91.0 $60,701 - $67,249
739 Added 1.22%
61,345 $5.34 Million
Q2 2020

Jul 21, 2020
SELL
$80.93 - $91.1 $92,745 - $104,400
-1,146 Reduced 1.86%
60,606 $5.29 Million
Q1 2020

Apr 28, 2020
BUY
$70.67 - $99.01 $90,457 - $126,732
1,280 Added 2.12%
61,752 $5.09 Million
Q4 2019

Jan 29, 2020
BUY
$84.35 - $95.37 $89,411 - $101,092
1,060 Added 1.78%
60,472 $5.73 Million
Q3 2019

Nov 01, 2019
BUY
$85.54 - $94.26 $189,556 - $208,880
2,216 Added 3.87%
59,412 $5.16 Million
Q2 2019

Aug 08, 2019
BUY
$75.4 - $92.8 $39,811 - $48,998
528 Added 0.93%
57,196 $5.22 Million
Q1 2019

May 08, 2019
BUY
$75.32 - $86.15 $8,661 - $9,907
115 Added 0.2%
56,668 $5.45 Million
Q4 2018

Feb 01, 2019
BUY
$73.66 - $82.02 $102,608 - $114,253
1,393 Added 2.53%
56,553 $4.85 Million
Q3 2018

Nov 01, 2018
BUY
$66.94 - $77.43 $89,030 - $102,981
1,330 Added 2.47%
55,160 $4.75 Million
Q2 2018

Jul 26, 2018
BUY
$64.91 - $73.36 $108,529 - $122,657
1,672 Added 3.21%
53,830 $4.07 Million
Q1 2018

Apr 17, 2018
BUY
$70.39 - $84.15 $10,417 - $12,454
148 Added 0.28%
52,158 $4.22 Million
Q4 2017

Jan 23, 2018
BUY
$72.33 - $77.64 $104,806 - $112,500
1,449 Added 2.87%
52,010 $4.37 Million
Q3 2017

Oct 30, 2017
BUY
$74.14 - $77.27 $3.75 Million - $3.91 Million
50,561
50,561 $4.34 Million

Others Institutions Holding NVS

# of Institutions
1,522
Shares Held
142M
Call Options Held
1.63M
Put Options Held
1.82M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $262B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Franklin, Parlapiano, Turner & Welch, LLC Portfolio

Follow Franklin, Parlapiano, Turner & Welch, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin, Parlapiano, Turner & Welch, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Franklin, Parlapiano, Turner & Welch, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email